Coatue Management
ADPT icon

Coatue Management’s Adaptive Biotechnologies ADPT Stock Holding History

Coatue Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,196
Closed -$275K – 156
2019
Q4 		$275K Buy
+9,196
New +$264K ﹤0.01% 318

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Coatue Management's ADPT Position: Q1 2020 in Review

Coatue Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2020, closing a stake of 9,196 shares — an estimated $275K sold.

Coatue Management first reported a position in ADPT in Q4 2019 and held it in 1 quarter. The position peaked at $275K in Q4 2019. 147 funds tracked by Wall St. Rank hold ADPT as of Q1 2020.

  • Coatue Management reported no remaining Adaptive Biotechnologies position as of Q1 2020 after selling out during the quarter.
  • Coatue Management sold 9,196 Adaptive Biotechnologies shares in Q1 2020, an estimated $275K.
  • Coatue Management first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 1 quarter.
  • Coatue Management's Adaptive Biotechnologies position peaked at $275K in Q4 2019.
  • 147 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2020.

Based on Coatue Management's 13F filing for Q1 2020, filed 15 May 2020.